407 related articles for article (PubMed ID: 29703944)
21. Characterization of De Novo Promoter Variants in Autism Spectrum Disorder with Massively Parallel Reporter Assays.
Koesterich J; An JY; Inoue F; Sohota A; Ahituv N; Sanders SJ; Kreimer A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834916
[TBL] [Abstract][Full Text] [Related]
22. The contribution of protein intrinsic disorder to understand the role of genetic variants uncovered by autism spectrum disorders exome studies.
Schuch JB; Paixão-Côrtes VR; Friedrich DC; Tovo-Rodrigues L
Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):479-91. PubMed ID: 26892727
[TBL] [Abstract][Full Text] [Related]
23. Finding underlying genetic mechanisms of two patients with autism spectrum disorder carrying familial apparently balanced chromosomal translocations.
Toraman B; Bilginer SÇ; Hesapçıoğlu ST; Göker Z; Soykam HO; Ergüner B; Dinçer T; Yıldız G; Ünsal S; Kasap BK; Kandil S; Kalay E
J Gene Med; 2021 Apr; 23(4):e3322. PubMed ID: 33591602
[TBL] [Abstract][Full Text] [Related]
24. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
Mol Autism; 2017; 8():14. PubMed ID: 28344757
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.
Toma C; Pierce KD; Shaw AD; Heath A; Mitchell PB; Schofield PR; Fullerton JM
PLoS Genet; 2018 Dec; 14(12):e1007535. PubMed ID: 30586385
[TBL] [Abstract][Full Text] [Related]
26. Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study.
Abdi M; Aliyev E; Trost B; Kohailan M; Aamer W; Syed N; Shaath R; Gandhi GD; Engchuan W; Howe J; Thiruvahindrapuram B; Geng M; Whitney J; Syed A; Lakshmi J; Hussein S; Albashir N; Hussein A; Poggiolini I; Elhag SF; Palaniswamy S; Kambouris M; de Fatima Janjua M; Tahir MOE; Nazeer A; Shahwar D; Azeem MW; Mokrab Y; Aati NA; Akil A; Scherer SW; Kamal M; Fakhro KA
Genome Med; 2023 Oct; 15(1):81. PubMed ID: 37805537
[TBL] [Abstract][Full Text] [Related]
27. Homozygous deletions implicate non-coding epigenetic marks in Autism spectrum disorder.
Schmitz-Abe K; Sanchez-Schmitz G; Doan RN; Hill RS; Chahrour MH; Mehta BK; Servattalab S; Ataman B; Lam AN; Morrow EM; Greenberg ME; Yu TW; Walsh CA; Markianos K
Sci Rep; 2020 Aug; 10(1):14045. PubMed ID: 32820185
[TBL] [Abstract][Full Text] [Related]
28. Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort.
Callaghan DB; Rogic S; Tan PPC; Calli K; Qiao Y; Baldwin R; Jacobson M; Belmadani M; Holmes N; Yu C; Li Y; Li Y; Kurtzke FE; Kuzeljevic B; Yu AY; Hudson M; Mcaughton AJM; Xu Y; Dionne-Laporte A; Girard S; Liang P; Separovic ER; Liu X; Rouleau G; Pavlidis P; Lewis MES
Clin Genet; 2019 Sep; 96(3):199-206. PubMed ID: 31038196
[TBL] [Abstract][Full Text] [Related]
29. Variation in the Untranslated Genome and Susceptibility to Infections.
Ramsuran V; Ewy R; Nguyen H; Kulkarni S
Front Immunol; 2018; 9():2046. PubMed ID: 30245696
[TBL] [Abstract][Full Text] [Related]
30. The Yin and Yang of Autism Genetics: How Rare De Novo and Common Variations Affect Liability.
Chaste P; Roeder K; Devlin B
Annu Rev Genomics Hum Genet; 2017 Aug; 18():167-187. PubMed ID: 28426285
[TBL] [Abstract][Full Text] [Related]
31. Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.
Lu J; Zhu Y; Williams S; Watts M; Tonta MA; Coleman HA; Parkington HC; Claudianos C
Transl Psychiatry; 2020 Dec; 10(1):418. PubMed ID: 33262327
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the regulatory function of non-coding autism-associated single nucleotide polymorphisms on gene expression in human brain tissue.
Pugsley K; Namipashaki A; Bellgrove MA; Hawi Z
Autism Res; 2024 Mar; 17(3):467-481. PubMed ID: 38323502
[TBL] [Abstract][Full Text] [Related]
33. Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.
Marco EJ; Aitken AB; Nair VP; da Gente G; Gerdes MR; Bologlu L; Thomas S; Sherr EH
BMC Med Genomics; 2018 May; 11(1):50. PubMed ID: 29801487
[TBL] [Abstract][Full Text] [Related]
34. Segregating patterns of copy number variations in extended autism spectrum disorder (ASD) pedigrees.
Woodbury-Smith M; Zarrei M; Wei J; Thiruvahindrapuram B; O'Connor I; Paterson AD; Yuen RKC; Dastan J; Stavropoulos DJ; Howe JL; Thompson A; Parlier M; Fernandez B; Piven J; Anagnostou E; Scherer SW; Vieland VJ; Szatmari P
Am J Med Genet B Neuropsychiatr Genet; 2020 Jul; 183(5):268-276. PubMed ID: 32372567
[TBL] [Abstract][Full Text] [Related]
35. Integrated genome-wide Alu methylation and transcriptome profiling analyses reveal novel epigenetic regulatory networks associated with autism spectrum disorder.
Saeliw T; Tangsuwansri C; Thongkorn S; Chonchaiya W; Suphapeetiporn K; Mutirangura A; Tencomnao T; Hu VW; Sarachana T
Mol Autism; 2018; 9():27. PubMed ID: 29686828
[TBL] [Abstract][Full Text] [Related]
36. AutismKB 2.0: a knowledgebase for the genetic evidence of autism spectrum disorder.
Yang C; Li J; Wu Q; Yang X; Huang AY; Zhang J; Ye AY; Dou Y; Yan L; Zhou WZ; Kong L; Wang M; Ai C; Yang D; Wei L
Database (Oxford); 2018 Jan; 2018():. PubMed ID: 30339214
[TBL] [Abstract][Full Text] [Related]
37. Genomic selection signatures in autism spectrum disorder identifies cognitive genomic tradeoff and its relevance in paradoxical phenotypes of deficits versus potentialities.
Prakash A; Banerjee M
Sci Rep; 2021 May; 11(1):10245. PubMed ID: 33986442
[TBL] [Abstract][Full Text] [Related]
38. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder.
Werling DM; Brand H; An JY; Stone MR; Zhu L; Glessner JT; Collins RL; Dong S; Layer RM; Markenscoff-Papadimitriou E; Farrell A; Schwartz GB; Wang HZ; Currall BB; Zhao X; Dea J; Duhn C; Erdman CA; Gilson MC; Yadav R; Handsaker RE; Kashin S; Klei L; Mandell JD; Nowakowski TJ; Liu Y; Pochareddy S; Smith L; Walker MF; Waterman MJ; He X; Kriegstein AR; Rubenstein JL; Sestan N; McCarroll SA; Neale BM; Coon H; Willsey AJ; Buxbaum JD; Daly MJ; State MW; Quinlan AR; Marth GT; Roeder K; Devlin B; Talkowski ME; Sanders SJ
Nat Genet; 2018 Apr; 50(5):727-736. PubMed ID: 29700473
[TBL] [Abstract][Full Text] [Related]
39. Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
Ruzzo EK; Pérez-Cano L; Jung JY; Wang LK; Kashef-Haghighi D; Hartl C; Singh C; Xu J; Hoekstra JN; Leventhal O; Leppä VM; Gandal MJ; Paskov K; Stockham N; Polioudakis D; Lowe JK; Prober DA; Geschwind DH; Wall DP
Cell; 2019 Aug; 178(4):850-866.e26. PubMed ID: 31398340
[TBL] [Abstract][Full Text] [Related]
40. Identification of De Novo JAK2 and MAPK7 Mutations Related to Autism Spectrum Disorder Using Whole-Exome Sequencing in a Chinese Child and Adolescent Trio-Based Sample.
Jiao J; Zhang M; Yang P; Huang Y; Hu X; Cai J; Yang C; Situ M; Zhang H; Fu L; Guo K; Huang Y
J Mol Neurosci; 2020 Feb; 70(2):219-229. PubMed ID: 31838722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
